The frequency of DGI as recently reported for CYP2D6, CYP2C19 and SLCO1B1 [45] further implies that a significant proportion of persons with diabetes will have phenotypes for which actions in principle should be taken regarding dose adjustment or avoidance of the given drugs. Here, CYP2D6 is linked to diabetes mellitus.